Two early-career pharmacists named joint winners of OPERA 2025 Qonita Anjani, a research fellow at Queen’s University Belfast, and Jennifer Stevenson, lead pharmacist for older adults at Guy’s and St. Thomas’ NHS Foundation Trust, London, were selected from a shortlist of five candidates.…
Pharmacy bodies warn that demand for weight-loss drug will outstrip supply Around 220,000 patients could be prescribed Mounjaro in the first three years of the drug's availability to NHS patients in England, the National Institute for Health and Care Excellence has estimated.…
Long-term plan for NHS workforce must follow 2026 Senedd elections, says RPS The Welsh NHS Confederation and Wellbeing Alliance, which is supported by the Royal Pharmaceutical Society, has urged the Welsh government to develop a workforce plan that expands training places and improves access to professional qualifications.…
Take-home naloxone: could community pharmacies be the answer to tackling drug deaths? Legislation to widen access to the opioid antidote naloxone came into force in December 2024. Experts say the community pharmacy network could use these changes to make sure this life-saving medicine reaches those who need it.…
No increase in NHS prescription fees for the first time in three years The government has announced that the single item prescription charge for 2025/2026 will remain at £9.90.…
Community pharmacy funding boosted by £617m in two-year contract Community Pharmacy England has announced that a £193m write-off of historic margin overspend has also been agreed with the government.…
RPS members vote ‘yes’ to becoming Royal College of Pharmacy The Royal Pharmaceutical Society will become a royal college by spring 2026 after 71.1% of members who voted were in favour of the proposal.…
What does the assisted dying legislation mean for pharmacy? The Terminally Ill Adults (End of Life) Bill still has a long way to go before becoming law and pharmacy organisations have unresolved questions about what it might mean for pharmacy practice.…
UK medicines regulation disincentivising investment in research development, finds survey The Association of the British Pharmaceutical Industry’s survey results accompany 12 recommendations for improving the Medicines and Healthcare Products Regulatory Agency’s effectiveness as a UK medicines regulator.…
Will reshoring medicines manufacturing solve shortages in the UK? In the United States and some European countries, drug manufacturing is being brought home to mitigate shortages of critical medicines, but would similar action in the UK shore up supply resilience?…